Spruce Biosciences, Inc. (SPRB) Tops Q2 EPS by 7c

Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q2 EPS of ($0.32), $0.07 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $750 thousand.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Argus starts SpaceX at Hold, sees record IPO as a multi-year re-rating challenge
• Freedom Broker Starts Copart (CPRT) at Buy